Laricca London1, Alejandra Hurtado-de-Mendoza2, Minna Song2, Ankita Nagirimadugu2, Gheorghe Luta3, Vanessa B Sheppard4. 1. Department of Microbiology, Howard University College of Medicine, Washington, DC, USA. 2. Department of Oncology, Georgetown University Medical Center and Georgetown-Lombardi Comprehensive Cancer Center, Breast Cancer Program, Washington, DC, USA. 3. Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University Medical Center and Georgetown-Lombardi Comprehensive Cancer Center, Cancer Prevention and Control Program, Washington, DC, USA. 4. Department of Oncology, Georgetown University Medical Center and Georgetown-Lombardi Comprehensive Cancer Center, Breast Cancer Program, Washington, DC, USA. Electronic address: vls3@georgetown.edu.
Abstract
OBJECTIVE: Latinas are underrepresented in clinical trials despite the rise in Hispanic population. This study examines the factors associated with Latinas' willingness to participate in preventive breast cancer randomized clinical trials (RCTs). METHODS: Women self-identifying as Latina, over age 40, with no prior history of breast cancer were eligible. Using the Behavior Model for Vulnerable Populations, we administered a survey (n=168) to assess predisposing (e.g., knowledge), enabling (e.g., trust) and need factors (e.g., risk perception). Intention to participate was defined using a lenient (maybe, probably or definitely) and a stringent criterion (probably and definitely). Chi-square tests and logistic regression models examined the associations of predisposing, enabling, and need factors with women's intentions to participate in RCTs. RESULTS: Most participants (74.9%) were monolingual Spanish-speaking immigrants. Most (83.9%) reported willing to participate in clinical trials using the lenient definition (vs. 43.1% under the stringent definition). Using the lenient definition, the odds of willing to participate in RCTs were significantly lower for unmarried women (OR=.25, 95% CI=.08-.79) and those with lower cancer risk perceptions (OR=.20, 95% CI=.06-.63), while being significantly higher for women with lower language acculturation (OR=6.2, 95% CI=1.8-20.9). Using the stringent definition, women who did not endorse a motivation to enroll to help family members (if they had cancer) had significantly lower odds to report intent (OR=.33, 95% CI=.13-.86). CONCLUSION: Many RCTs may have limited generalizability due to the low representation of minorities. Culturally targeted interventions that address the importance of family for Latinos may ultimately increase their participation in RCTs.
OBJECTIVE: Latinas are underrepresented in clinical trials despite the rise in Hispanic population. This study examines the factors associated with Latinas' willingness to participate in preventive breast cancer randomized clinical trials (RCTs). METHODS:Women self-identifying as Latina, over age 40, with no prior history of breast cancer were eligible. Using the Behavior Model for Vulnerable Populations, we administered a survey (n=168) to assess predisposing (e.g., knowledge), enabling (e.g., trust) and need factors (e.g., risk perception). Intention to participate was defined using a lenient (maybe, probably or definitely) and a stringent criterion (probably and definitely). Chi-square tests and logistic regression models examined the associations of predisposing, enabling, and need factors with women's intentions to participate in RCTs. RESULTS: Most participants (74.9%) were monolingual Spanish-speaking immigrants. Most (83.9%) reported willing to participate in clinical trials using the lenient definition (vs. 43.1% under the stringent definition). Using the lenient definition, the odds of willing to participate in RCTs were significantly lower for unmarried women (OR=.25, 95% CI=.08-.79) and those with lower cancer risk perceptions (OR=.20, 95% CI=.06-.63), while being significantly higher for women with lower language acculturation (OR=6.2, 95% CI=1.8-20.9). Using the stringent definition, women who did not endorse a motivation to enroll to help family members (if they had cancer) had significantly lower odds to report intent (OR=.33, 95% CI=.13-.86). CONCLUSION: Many RCTs may have limited generalizability due to the low representation of minorities. Culturally targeted interventions that address the importance of family for Latinos may ultimately increase their participation in RCTs.
Authors: Jean G Ford; Mollie W Howerton; Gabriel Y Lai; Tiffany L Gary; Shari Bolen; M Chris Gibbons; Jon Tilburt; Charles Baffi; Teerath Peter Tanpitukpongse; Renee F Wilson; Neil R Powe; Eric B Bass Journal: Cancer Date: 2008-01-15 Impact factor: 6.860
Authors: Jeanne Mandelblatt; Elizabeth Kaufman; Vanessa B Sheppard; Jyl Pomeroy; John Kavanaugh; Janet Canar; Laura Pallandre; Jennifer Cullen; Elmer Huerta Journal: Prev Med Date: 2005-06 Impact factor: 4.018
Authors: Marielena Lara; Cristina Gamboa; M Iya Kahramanian; Leo S Morales; David E Hayes Bautista Journal: Annu Rev Public Health Date: 2005 Impact factor: 21.870
Authors: Sally C Moyce; Nathaniel Sisson; Sophia Thompson; Maria Velazqueaz; David Claudio; Elizabeth Aghbashian; Heather Demorest; Karl Vanderwood Journal: Am J Health Educ Date: 2021-02-17
Authors: Heather Greenlee; Ann Ogden Gaffney; A Corina Aycinena; Pam Koch; Isobel Contento; Wahida Karmally; John M Richardson; Zaixing Shi; Emerson Lim; Wei-Yann Tsai; Regina M Santella; William S Blaner; Robin D Clugston; Serge Cremers; Susan Pollak; Iryna Sirosh; Katherine D Crew; Matthew Maurer; Kevin Kalinsky; Dawn L Hershman Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-07-26 Impact factor: 4.254
Authors: Zachary R Simoni; Michelle Martin; Jennifer A Wenzel; Elise D Cook; Badrinath Konety; Selwyn M Vickers; Moon S Chen; Mona N Foaud; Raegan W Durant Journal: J Racial Ethn Health Disparities Date: 2016-11-08
Authors: Susan L Rosenthal; Ariel M de Roche; Marina Catallozzi; Carmen Radecki Breitkopf; Lisa S Ipp; Jane Chang; Jenny K R Francis; Mei-Chen Hu Journal: J Pediatr Adolesc Gynecol Date: 2016-01-25 Impact factor: 1.814
Authors: Andrew R Wong; Virginia Sun; Kevin George; Jennifer Liu; Simran Padam; Brandon A Chen; Thomas George; Arya Amini; Daneng Li; Mina S Sedrak Journal: JCO Oncol Pract Date: 2020-04-02